How many insider trades does FilingIQ track for NXTC?

FilingIQ tracks 44 Form 4 insider transactions for NXTC (NextCure, Inc.), covering filings from May 13, 2019 onwards. 6 of those were filed in the last 90 days.

Are NXTC insiders net buyers or net sellers?

Across the full Form 4 history for NXTC, 7 transactions (16%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NXTC insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NXTC in?

NextCure, Inc. (NXTC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $45.99M.

NXTC insider trading

Healthcare

NextCure, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

16% / 0%

Market cap

$45.99M

About NextCure, Inc.

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.

Company website: www.nextcure.com

NXTC insider activity at a glance

FilingIQ has scored 44 insider transactions for NXTC since May 13, 2019. The most recent filing in our index is dated Jun 18, 2026.

Across the full history, 7 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NXTC insider trades is 54.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NXTC trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,196

UNITED THERAPEUTICS Corp

APLS 275

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 191

Guardant Health, Inc.

First Tracks Biotherapeutics, Inc.

NTRA 133

Natera, Inc.

Frequently asked

How many insider trades does FilingIQ track for NXTC?: FilingIQ tracks 44 Form 4 insider transactions for NXTC (NextCure, Inc.), covering filings from May 13, 2019 onwards. 6 of those were filed in the last 90 days.
Are NXTC insiders net buyers or net sellers?: Across the full Form 4 history for NXTC, 7 transactions (16%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NXTC insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NXTC in?: NextCure, Inc. (NXTC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $45.99M.

Methodology & sources

Every NXTC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.